ubenimex has been researched along with Cancer of Esophagus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DuBois, RN | 1 |
| Beer, DG; Chen, X; Hong, J; Jiao, X; Krasna, MJ; Li, N; Wang, S; Wu, N; Yang, CS | 1 |
| Arai, Y; Endo, M; Ide, H; Isono, K; Makuuchi, H; Mitomi, T; Nabeya, K; Sato, H; Taguchi, G | 1 |
3 other study(ies) available for ubenimex and Cancer of Esophagus
| Article | Year |
|---|---|
Leukotriene A4 signaling, inflammation, and cancer.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Arachidonate 5-Lipoxygenase; Cell Transformation, Neoplastic; Cyclooxygenase Inhibitors; Disease Models, Animal; Epoxide Hydrolases; Esophageal Neoplasms; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Inflammation; Leucine; Leukotriene A4; Neoplasms; Signal Transduction; Up-Regulation | 2003 |
Leukotriene A4 hydrolase in rat and human esophageal adenocarcinomas and inhibitory effects of bestatin.
Topics: Adenocarcinoma; Anastomosis, Surgical; Animals; Antibiotics, Antineoplastic; Blotting, Western; Chemoprevention; Disease Models, Animal; Duodenum; Epoxide Hydrolases; Esophageal Neoplasms; Esophagus; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Incidence; Inflammation; Leucine; Leukotriene A4; Rats; Stomach; Treatment Outcome; Up-Regulation | 2003 |
[Effect of bestatin on primary tumor and prognosis in patient with esophageal carcinoma].
Topics: Adjuvants, Immunologic; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Humans; Leucine; Male; Middle Aged; Prognosis | 1984 |